Can-Fite BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CANF and other ETFs, options, and stocks.About CANF
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602.
CEOMotti Farbstein
CEOMotti Farbstein
Employees5
Employees5
HeadquartersRamat Gan, HaMerkaz
HeadquartersRamat Gan, HaMerkaz
Founded1994
Founded1994
Employees5
Employees5
CANF Key Statistics
Market cap5.99M
Market cap5.99M
Price-Earnings ratio-0.19
Price-Earnings ratio-0.19
Dividend yield—
Dividend yield—
Average volume2.08M
Average volume2.08M
High today$2.48
High today$2.48
Low today$2.32
Low today$2.32
Open price$2.44
Open price$2.44
Volume329.66K
Volume329.66K
52 Week high$13.40
52 Week high$13.40
52 Week low$2.32
52 Week low$2.32
CANF News
TipRanks 18h
Can-Fite BioPharma Cuts Warrant Exercise Price to Secure $4 Million Inducement FinancingThe latest update is out from Can-Fite BioPharma ( (CANF) ). On September 2, 2026, Can-Fite BioPharma entered into an inducement offer with a holder of its Mar...
TipRanks 2d
Can-Fite reports longer-than-anticipated survival observed in Namodenoson studyCan-Fite BioPharma (CANF) announced that blinded overall survival observed across the entire patient population in its ongoing pivotal Phase III study of Namode...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.